| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 707904 | Null | 0.0105972823829604 | 0.36477845 |
| NSC 709483 | Null | 0.0105972823829604 | 0.44633599 |
| NSC 714379 | Null | 0.0105972823829604 | 0.55110231 |
| NSC 716951 | Null | 0.0105972823829604 | 0.37724852 |
| NSC 720299 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane | 0.0105972823829604 | 0.51838746 |
| NSC 720386 | Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane | 0.0105972823829604 | 0.46979031 |
| NSC 722867 | Null | 0.0105972823829604 | 0.49069085 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0105972823829604 | 0.22667119 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0105972823829604 | 0.54178016 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.0105972823829604 | 0.40457731 |